Arcturus Therapeutics's total assets for Q3 2024 were $370.65M, a decrease of -4.62% from the previous quarter. ARCT total liabilities were $108.79M for the fiscal quarter, a -16.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.